Actos
3.4 (4 customer reviews)Actos is an oral pioglitazone medicine for adults with type 2 diabetes. It helps improve insulin sensitivity so the body can use glucose more effectively and achieve better long-term blood sugar control.
Description
Actos is a tablet containing pioglitazone for adults with type 2 diabetes. It is used when diet, physical activity, and other glucose-lowering measures do not achieve adequate blood sugar control. Pioglitazone improves the body’s response to insulin, helping muscle, fat, and liver cells use glucose more effectively [1].
Composition
Actos contains pioglitazone, an oral antidiabetic medicine from the thiazolidinedione class. Thiazolidinediones are also called glitazones. They work differently from medicines that increase insulin release directly.
Pioglitazone is intended for type 2 diabetes in adults. It does not treat type 1 diabetes and is not used to manage diabetic ketoacidosis.
One practical point: Actos lowers blood glucose gradually. It is not designed to correct a sudden high glucose reading within hours.
Dosage and usage
Actos is taken by mouth once daily, with water. It can be taken with or without food, and choosing the same time each day makes the routine easier to maintain.
The prescribed dose depends on blood glucose results, HbA1c, liver function, other diabetes medicines, and individual tolerability. Dose changes are usually made gradually rather than after a few isolated glucose readings.
- Swallow the tablet whole with water.
- Take it at a consistent time each day.
- Continue dietary and activity measures alongside the tablet.
- If a dose is missed, take it when remembered unless the next dose is due soon.
- Do not take two tablets together to make up for a forgotten dose.
Pioglitazone may be used with metformin, sulphonylureas, or insulin, though combination treatment changes the risk of low blood sugar. The MHRA-approved prescribing information advises individual dose adjustment when pioglitazone is added to therapies that can cause hypoglycaemia [3].
How it works
Pioglitazone activates a receptor called PPAR-gamma, found mainly in fat cells, muscle tissue, and the liver. PPAR-gamma influences genes involved in glucose and fat metabolism. When this receptor is activated, cells become more responsive to the insulin produced by the pancreas.
Insulin acts like a signal that helps glucose move from the blood into cells. In insulin resistance, that signal is weakened. Actos helps restore the response, so glucose uptake and use improve.
Pioglitazone does not usually cause low blood sugar by itself because it does not force the pancreas to release insulin [2].
Indications
Actos is prescribed to improve long-term blood sugar control in adults whose type 2 diabetes remains above target despite lifestyle measures or other treatments. It may be used alone when certain first-line medicines are unsuitable, or alongside other glucose-lowering medicines.
Type 2 diabetes develops when the body’s cells become less responsive to insulin. The pancreas still produces insulin, yet glucose remains in the bloodstream rather than moving efficiently into cells for energy.
Doctors may use pioglitazone with:
- metformin;
- a sulphonylurea;
- insulin;
- selected newer diabetes treatments, where clinically appropriate.
Better insulin sensitivity can lower HbA1c, the blood test that reflects average glucose control over roughly two to three months.
Comparison
Thiazolidinediones are insulin sensitizers. Their key advantage is that they target insulin resistance rather than simply increasing insulin production.
| Treatment approach | Main action | Key limitation |
|---|---|---|
| Actos / pioglitazone | Improves insulin sensitivity | Can cause fluid retention and weight gain |
| Metformin | Reduces liver glucose production | Can cause stomach upset |
| Insulin | Directly lowers glucose | Can cause hypoglycaemia and weight gain |
Metformin is often used early in type 2 diabetes because it has a long clinical track record and does not usually cause weight gain. Pioglitazone may be considered when insulin resistance remains a major issue or when other treatments are not tolerated.
Insulin lowers blood glucose directly and may be essential when the body cannot make enough insulin. Combining insulin with pioglitazone needs care because fluid retention and heart failure risk can increase.
Contraindications
- active bladder cancer or a history of bladder cancer;
- unexplained blood in the urine;
- diabetic ketoacidosis;
- severe liver disease;
- known allergy to pioglitazone or tablet ingredients;
- pregnancy or breastfeeding, unless a specialist has made a clear treatment plan.
People using insulin need extra caution because the combination can increase fluid retention. Regular review of weight, swelling, breathing symptoms, liver tests, and blood glucose control forms part of responsible treatment with pioglitazone [5].
When this is not for you
This medicine is not for you if you have heart failure or a history of heart failure. Pioglitazone can cause fluid retention, which may worsen heart failure.
Actos should also be avoided or carefully assessed in people with active bladder cancer or a history of bladder cancer, unexplained blood in the urine, diabetic ketoacidosis, severe liver disease, an allergy to pioglitazone or tablet ingredients, or pregnancy or breastfeeding unless a specialist has made a clear treatment plan.
Diabetic ketoacidosis, often called DKA, is a medical emergency caused by a severe lack of usable insulin. Symptoms include excessive thirst, frequent urination, nausea, vomiting, deep breathing, abdominal pain, fruity-smelling breath, and marked drowsiness. Actos is not a treatment for DKA.
Side effects
Weight gain and fluid retention are among the most relevant adverse effects of pioglitazone. Weight gain may reflect increased fat storage, fluid retention, or both. Swollen ankles, tight shoes, rapid weight change, or breathlessness need prompt clinical assessment.
Commonly reported effects include:
- weight gain;
- ankle or leg swelling;
- upper respiratory infections;
- headache;
- muscle aches;
- numbness or tingling;
- blurred vision caused by changing glucose levels.
Low blood sugar is more likely when Actos is used with insulin or a sulphonylurea. Symptoms can include sweating, shakiness, hunger, dizziness, palpitations, headache, or confusion. Treating recurrent hypos may require adjustment of the accompanying diabetes medicine.
Serious symptoms need urgent medical advice. These include increasing shortness of breath, chest discomfort, waking at night breathless, rapid swelling, severe abdominal pain with vomiting, yellowing of the skin or eyes, or blood in the urine.
Pioglitazone has also been associated with a higher fracture risk, mainly in women, and a small bladder cancer concern has led to restrictions for people with current or previous bladder cancer [4].
Common mistakes
Several avoidable habits reduce the benefit of Actos or delay recognition of side effects.
- Stopping treatment after a few days because glucose readings have not changed much.
- Doubling a dose after forgetting a tablet.
- Ignoring gradual weight gain or ankle swelling.
- Assuming hypoglycaemia cannot happen while using Actos with insulin or a sulphonylurea.
- Treating symptoms of a urinary infection or blood in the urine without reporting them.
- Changing diabetes medicines independently after a single high reading.
Actos works best when it is taken consistently and assessed using planned clinical measures. A single takeaway meal, illness, poor sleep, steroid treatment, or missed tablets can raise glucose temporarily and distort the picture.
What doctors say
In clinical practice, doctors often consider pioglitazone when insulin resistance is prominent and blood glucose remains above target despite another oral treatment. The response is not immediate, so treatment decisions are usually based on trends in HbA1c, weight, symptoms, and glucose monitoring rather than one difficult week.
The trade-off is clear. Actos can improve insulin sensitivity without causing hypoglycaemia when taken alone, yet weight gain and oedema can limit its suitability. For a person with heart failure symptoms, this trade-off is usually unacceptable.
Doctors also watch for changes in menstrual regularity. Improved insulin sensitivity can restore ovulation in some women with insulin resistance, so contraception planning may need review.
Frequently asked questions
How long does Actos take to improve blood sugar?
Pioglitazone works gradually because it changes insulin sensitivity rather than creating an immediate insulin surge. Some glucose readings may improve within weeks, while HbA1c is commonly reviewed after a longer period of consistent use. The 2024 EMA product information describes pioglitazone as a treatment for ongoing glycaemic control, not rapid correction of high blood glucose .
Can Actos cause weight gain?
Yes. Weight gain is a recognised effect of pioglitazone and may result from fluid retention, changes in fat distribution, or both. Rapid weight gain, swollen ankles, or breathlessness need medical assessment because they can indicate fluid overload. The 2024 EMA safety information has highlighted the need to consider bladder and cardiovascular risks when selecting patients for pioglitazone .
Can Actos be taken with metformin?
Actos may be prescribed with metformin when one treatment alone does not provide enough glucose control. The medicines have different actions, which can make the combination useful for some adults with type 2 diabetes. Dose selection depends on glucose results, kidney function, tolerability, and the rest of the diabetes regimen. The 2022 NICE guidance for type 2 diabetes supports individualised treatment choices based on clinical need and treatment risks .
Does Actos cause low blood sugar?
Actos taken alone has a low risk of hypoglycaemia because it does not directly stimulate insulin release. The risk rises when it is combined with insulin or a sulphonylurea. Symptoms such as sweating, trembling, confusion, hunger, or palpitations should be treated as possible low blood sugar until checked. The 2024 MHRA prescribing information advises considering reduction of the accompanying insulin or sulphonylurea dose when needed .
Who should avoid Actos?
People with heart failure, active bladder cancer, previous bladder cancer, unexplained blood in the urine, or diabetic ketoacidosis should not use pioglitazone. Caution is also needed in liver disease and in people at increased fracture risk. The 2023 WHO guidance describes type 2 diabetes care as requiring treatment choices tailored to the person’s risks, glucose profile, and coexisting conditions .
Can Actos be used for a long time?
Long-term use may be appropriate when blood glucose control improves and the medicine remains well tolerated. Ongoing monitoring matters because weight, fluid retention, liver function, fracture risk, and urinary symptoms can change over time. A planned HbA1c review gives a clearer measure of benefit than judging treatment from occasional home readings. The 2022 NICE guidance recommends regular review and adjustment of diabetes treatment when targets are not met or adverse effects develop .
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Comparison
Abana
Abhigra
Abilify
Accutane
Actonel
Actos: Reviews and Experiences
Sources
- European Medicines Agency (2024). Pioglitazone: Summary of Product Characteristics.
- World Health Organization (2023). Package of Essential Noncommunicable Disease Interventions for Primary Health Care: Diabetes Management.
- Medicines and Healthcare products Regulatory Agency (2024). Pioglitazone Tablets: Summary of Product Characteristics.
- European Medicines Agency (2011). European Medicines Agency recommends new contra-indications and warnings for pioglitazone to reduce small increased risk of bladder cancer.
- National Institute for Health and Care Excellence (2022). Type 2 diabetes in adults: management (NG28).